GO:0090136 | epithelial cell-cell adhesion | 8.30e-06 | 8.10e-02 | 8.668 | 2 | 2 | 4 |
GO:0050998 | nitric-oxide synthase binding | 6.20e-05 | 6.05e-01 | 7.347 | 2 | 2 | 10 |
GO:0043234 | protein complex | 8.99e-05 | 8.77e-01 | 3.954 | 4 | 8 | 210 |
GO:0036464 | cytoplasmic ribonucleoprotein granule | 2.34e-04 | 1.00e+00 | 6.421 | 2 | 4 | 19 |
GO:0034613 | cellular protein localization | 4.43e-04 | 1.00e+00 | 5.968 | 2 | 2 | 26 |
GO:0034332 | adherens junction organization | 5.14e-04 | 1.00e+00 | 5.861 | 2 | 3 | 28 |
GO:0000978 | RNA polymerase II core promoter proximal region sequence-specific DNA binding | 6.02e-04 | 1.00e+00 | 4.104 | 3 | 4 | 142 |
GO:0021762 | substantia nigra development | 7.60e-04 | 1.00e+00 | 5.581 | 2 | 2 | 34 |
GO:0030175 | filopodium | 9.00e-04 | 1.00e+00 | 5.459 | 2 | 2 | 37 |
GO:0030038 | contractile actin filament bundle assembly | 1.23e-03 | 1.00e+00 | 9.668 | 1 | 1 | 1 |
GO:0045556 | positive regulation of TRAIL biosynthetic process | 1.23e-03 | 1.00e+00 | 9.668 | 1 | 1 | 1 |
GO:0090287 | regulation of cellular response to growth factor stimulus | 1.23e-03 | 1.00e+00 | 9.668 | 1 | 1 | 1 |
GO:1900222 | negative regulation of beta-amyloid clearance | 1.23e-03 | 1.00e+00 | 9.668 | 1 | 1 | 1 |
GO:0090230 | regulation of centromere complex assembly | 1.23e-03 | 1.00e+00 | 9.668 | 1 | 1 | 1 |
GO:0014819 | regulation of skeletal muscle contraction | 1.23e-03 | 1.00e+00 | 9.668 | 1 | 1 | 1 |
GO:0031134 | sister chromatid biorientation | 1.23e-03 | 1.00e+00 | 9.668 | 1 | 1 | 1 |
GO:0046016 | positive regulation of transcription by glucose | 1.23e-03 | 1.00e+00 | 9.668 | 1 | 1 | 1 |
GO:0008134 | transcription factor binding | 1.84e-03 | 1.00e+00 | 3.546 | 3 | 5 | 209 |
GO:0031175 | neuron projection development | 1.98e-03 | 1.00e+00 | 4.887 | 2 | 2 | 55 |
GO:0051683 | establishment of Golgi localization | 2.46e-03 | 1.00e+00 | 8.668 | 1 | 1 | 2 |
GO:0071338 | positive regulation of hair follicle cell proliferation | 2.46e-03 | 1.00e+00 | 8.668 | 1 | 1 | 2 |
GO:0003257 | positive regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation | 2.46e-03 | 1.00e+00 | 8.668 | 1 | 1 | 2 |
GO:0014809 | regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion | 2.46e-03 | 1.00e+00 | 8.668 | 1 | 1 | 2 |
GO:2000651 | positive regulation of sodium ion transmembrane transporter activity | 2.46e-03 | 1.00e+00 | 8.668 | 1 | 1 | 2 |
GO:0060661 | submandibular salivary gland formation | 2.46e-03 | 1.00e+00 | 8.668 | 1 | 1 | 2 |
GO:0035088 | establishment or maintenance of apical/basal cell polarity | 2.46e-03 | 1.00e+00 | 8.668 | 1 | 1 | 2 |
GO:0051835 | positive regulation of synapse structural plasticity | 2.46e-03 | 1.00e+00 | 8.668 | 1 | 1 | 2 |
GO:0090135 | actin filament branching | 2.46e-03 | 1.00e+00 | 8.668 | 1 | 1 | 2 |
GO:1901385 | regulation of voltage-gated calcium channel activity | 2.46e-03 | 1.00e+00 | 8.668 | 1 | 1 | 2 |
GO:0034088 | maintenance of mitotic sister chromatid cohesion | 2.46e-03 | 1.00e+00 | 8.668 | 1 | 1 | 2 |
GO:0086001 | cardiac muscle cell action potential | 2.46e-03 | 1.00e+00 | 8.668 | 1 | 1 | 2 |
GO:0090231 | regulation of spindle checkpoint | 2.46e-03 | 1.00e+00 | 8.668 | 1 | 1 | 2 |
GO:0072384 | organelle transport along microtubule | 2.46e-03 | 1.00e+00 | 8.668 | 1 | 1 | 2 |
GO:0010736 | serum response element binding | 2.46e-03 | 1.00e+00 | 8.668 | 1 | 1 | 2 |
GO:0007070 | negative regulation of transcription from RNA polymerase II promoter during mitosis | 2.46e-03 | 1.00e+00 | 8.668 | 1 | 1 | 2 |
GO:0005200 | structural constituent of cytoskeleton | 3.01e-03 | 1.00e+00 | 4.581 | 2 | 4 | 68 |
GO:0038096 | Fc-gamma receptor signaling pathway involved in phagocytosis | 3.19e-03 | 1.00e+00 | 4.539 | 2 | 3 | 70 |
GO:0007143 | female meiotic division | 3.68e-03 | 1.00e+00 | 8.083 | 1 | 1 | 3 |
GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding | 3.68e-03 | 1.00e+00 | 8.083 | 1 | 1 | 3 |
GO:0022028 | tangential migration from the subventricular zone to the olfactory bulb | 3.68e-03 | 1.00e+00 | 8.083 | 1 | 1 | 3 |
GO:0060947 | cardiac vascular smooth muscle cell differentiation | 3.68e-03 | 1.00e+00 | 8.083 | 1 | 1 | 3 |
GO:0003161 | cardiac conduction system development | 3.68e-03 | 1.00e+00 | 8.083 | 1 | 1 | 3 |
GO:0071459 | protein localization to chromosome, centromeric region | 3.68e-03 | 1.00e+00 | 8.083 | 1 | 1 | 3 |
GO:0010669 | epithelial structure maintenance | 3.68e-03 | 1.00e+00 | 8.083 | 1 | 1 | 3 |
GO:0033561 | regulation of water loss via skin | 3.68e-03 | 1.00e+00 | 8.083 | 1 | 1 | 3 |
GO:0010735 | positive regulation of transcription via serum response element binding | 3.68e-03 | 1.00e+00 | 8.083 | 1 | 1 | 3 |
GO:0060684 | epithelial-mesenchymal cell signaling | 3.68e-03 | 1.00e+00 | 8.083 | 1 | 1 | 3 |
GO:0016013 | syntrophin complex | 3.68e-03 | 1.00e+00 | 8.083 | 1 | 1 | 3 |
GO:0044233 | ER-mitochondrion membrane contact site | 3.68e-03 | 1.00e+00 | 8.083 | 1 | 1 | 3 |
GO:1902083 | negative regulation of peptidyl-cysteine S-nitrosylation | 3.68e-03 | 1.00e+00 | 8.083 | 1 | 1 | 3 |
GO:0071930 | negative regulation of transcription involved in G1/S transition of mitotic cell cycle | 3.68e-03 | 1.00e+00 | 8.083 | 1 | 1 | 3 |
GO:0008285 | negative regulation of cell proliferation | 4.11e-03 | 1.00e+00 | 3.140 | 3 | 3 | 277 |
GO:0071922 | regulation of cohesin localization to chromatin | 4.91e-03 | 1.00e+00 | 7.668 | 1 | 2 | 4 |
GO:0034191 | apolipoprotein A-I receptor binding | 4.91e-03 | 1.00e+00 | 7.668 | 1 | 1 | 4 |
GO:0036336 | dendritic cell migration | 4.91e-03 | 1.00e+00 | 7.668 | 1 | 1 | 4 |
GO:0044458 | motile cilium assembly | 4.91e-03 | 1.00e+00 | 7.668 | 1 | 1 | 4 |
GO:0048664 | neuron fate determination | 4.91e-03 | 1.00e+00 | 7.668 | 1 | 1 | 4 |
GO:0043043 | peptide biosynthetic process | 4.91e-03 | 1.00e+00 | 7.668 | 1 | 1 | 4 |
GO:0051150 | regulation of smooth muscle cell differentiation | 4.91e-03 | 1.00e+00 | 7.668 | 1 | 1 | 4 |
GO:0030157 | pancreatic juice secretion | 4.91e-03 | 1.00e+00 | 7.668 | 1 | 1 | 4 |
GO:0043550 | regulation of lipid kinase activity | 4.91e-03 | 1.00e+00 | 7.668 | 1 | 1 | 4 |
GO:0031256 | leading edge membrane | 4.91e-03 | 1.00e+00 | 7.668 | 1 | 1 | 4 |
GO:0035189 | Rb-E2F complex | 4.91e-03 | 1.00e+00 | 7.668 | 1 | 1 | 4 |
GO:0034349 | glial cell apoptotic process | 4.91e-03 | 1.00e+00 | 7.668 | 1 | 1 | 4 |
GO:0048554 | positive regulation of metalloenzyme activity | 4.91e-03 | 1.00e+00 | 7.668 | 1 | 1 | 4 |
GO:0061024 | membrane organization | 5.11e-03 | 1.00e+00 | 4.193 | 2 | 3 | 89 |
GO:0006457 | protein folding | 6.04e-03 | 1.00e+00 | 4.069 | 2 | 2 | 97 |
GO:0007097 | nuclear migration | 6.13e-03 | 1.00e+00 | 7.347 | 1 | 2 | 5 |
GO:0031274 | positive regulation of pseudopodium assembly | 6.13e-03 | 1.00e+00 | 7.347 | 1 | 1 | 5 |
GO:0003334 | keratinocyte development | 6.13e-03 | 1.00e+00 | 7.347 | 1 | 1 | 5 |
GO:0045842 | positive regulation of mitotic metaphase/anaphase transition | 6.13e-03 | 1.00e+00 | 7.347 | 1 | 1 | 5 |
GO:0090009 | primitive streak formation | 6.13e-03 | 1.00e+00 | 7.347 | 1 | 1 | 5 |
GO:0002162 | dystroglycan binding | 6.13e-03 | 1.00e+00 | 7.347 | 1 | 1 | 5 |
GO:0060055 | angiogenesis involved in wound healing | 6.13e-03 | 1.00e+00 | 7.347 | 1 | 1 | 5 |
GO:0048667 | cell morphogenesis involved in neuron differentiation | 6.13e-03 | 1.00e+00 | 7.347 | 1 | 1 | 5 |
GO:0030957 | Tat protein binding | 6.13e-03 | 1.00e+00 | 7.347 | 1 | 1 | 5 |
GO:0035912 | dorsal aorta morphogenesis | 6.13e-03 | 1.00e+00 | 7.347 | 1 | 1 | 5 |
GO:0043353 | enucleate erythrocyte differentiation | 7.35e-03 | 1.00e+00 | 7.083 | 1 | 1 | 6 |
GO:0043589 | skin morphogenesis | 7.35e-03 | 1.00e+00 | 7.083 | 1 | 1 | 6 |
GO:0070688 | MLL5-L complex | 7.35e-03 | 1.00e+00 | 7.083 | 1 | 1 | 6 |
GO:0051489 | regulation of filopodium assembly | 7.35e-03 | 1.00e+00 | 7.083 | 1 | 1 | 6 |
GO:0060789 | hair follicle placode formation | 7.35e-03 | 1.00e+00 | 7.083 | 1 | 1 | 6 |
GO:0060136 | embryonic process involved in female pregnancy | 7.35e-03 | 1.00e+00 | 7.083 | 1 | 1 | 6 |
GO:0000075 | cell cycle checkpoint | 7.35e-03 | 1.00e+00 | 7.083 | 1 | 1 | 6 |
GO:0045987 | positive regulation of smooth muscle contraction | 7.35e-03 | 1.00e+00 | 7.083 | 1 | 1 | 6 |
GO:0060047 | heart contraction | 7.35e-03 | 1.00e+00 | 7.083 | 1 | 1 | 6 |
GO:0043497 | regulation of protein heterodimerization activity | 7.35e-03 | 1.00e+00 | 7.083 | 1 | 1 | 6 |
GO:0000790 | nuclear chromatin | 7.57e-03 | 1.00e+00 | 3.900 | 2 | 2 | 109 |
GO:0070062 | extracellular vesicular exosome | 8.22e-03 | 1.00e+00 | 1.573 | 6 | 28 | 1641 |
GO:0051988 | regulation of attachment of spindle microtubules to kinetochore | 8.57e-03 | 1.00e+00 | 6.861 | 1 | 1 | 7 |
GO:0060261 | positive regulation of transcription initiation from RNA polymerase II promoter | 8.57e-03 | 1.00e+00 | 6.861 | 1 | 1 | 7 |
GO:0001076 | RNA polymerase II transcription factor binding transcription factor activity | 8.57e-03 | 1.00e+00 | 6.861 | 1 | 1 | 7 |
GO:0055003 | cardiac myofibril assembly | 8.57e-03 | 1.00e+00 | 6.861 | 1 | 1 | 7 |
GO:0045059 | positive thymic T cell selection | 8.57e-03 | 1.00e+00 | 6.861 | 1 | 1 | 7 |
GO:0030126 | COPI vesicle coat | 8.57e-03 | 1.00e+00 | 6.861 | 1 | 1 | 7 |
GO:0043149 | stress fiber assembly | 9.79e-03 | 1.00e+00 | 6.668 | 1 | 1 | 8 |
GO:0051233 | spindle midzone | 9.79e-03 | 1.00e+00 | 6.668 | 1 | 1 | 8 |
GO:0042535 | positive regulation of tumor necrosis factor biosynthetic process | 9.79e-03 | 1.00e+00 | 6.668 | 1 | 1 | 8 |
GO:0030424 | axon | 1.03e-02 | 1.00e+00 | 3.668 | 2 | 4 | 128 |
GO:0016020 | membrane | 1.07e-02 | 1.00e+00 | 1.753 | 5 | 25 | 1207 |
GO:0031996 | thioesterase binding | 1.10e-02 | 1.00e+00 | 6.499 | 1 | 1 | 9 |
GO:0072583 | clathrin-mediated endocytosis | 1.10e-02 | 1.00e+00 | 6.499 | 1 | 1 | 9 |
GO:0097284 | hepatocyte apoptotic process | 1.10e-02 | 1.00e+00 | 6.499 | 1 | 1 | 9 |
GO:0000983 | RNA polymerase II core promoter sequence-specific DNA binding transcription factor activity | 1.10e-02 | 1.00e+00 | 6.499 | 1 | 1 | 9 |
GO:0061029 | eyelid development in camera-type eye | 1.10e-02 | 1.00e+00 | 6.499 | 1 | 1 | 9 |
GO:0060292 | long term synaptic depression | 1.10e-02 | 1.00e+00 | 6.499 | 1 | 1 | 9 |
GO:0060218 | hematopoietic stem cell differentiation | 1.10e-02 | 1.00e+00 | 6.499 | 1 | 1 | 9 |
GO:0002011 | morphogenesis of an epithelial sheet | 1.10e-02 | 1.00e+00 | 6.499 | 1 | 1 | 9 |
GO:0017166 | vinculin binding | 1.22e-02 | 1.00e+00 | 6.347 | 1 | 1 | 10 |
GO:0042551 | neuron maturation | 1.22e-02 | 1.00e+00 | 6.347 | 1 | 1 | 10 |
GO:0045651 | positive regulation of macrophage differentiation | 1.22e-02 | 1.00e+00 | 6.347 | 1 | 1 | 10 |
GO:0043488 | regulation of mRNA stability | 1.22e-02 | 1.00e+00 | 6.347 | 1 | 1 | 10 |
GO:0016010 | dystrophin-associated glycoprotein complex | 1.22e-02 | 1.00e+00 | 6.347 | 1 | 1 | 10 |
GO:0060314 | regulation of ryanodine-sensitive calcium-release channel activity | 1.22e-02 | 1.00e+00 | 6.347 | 1 | 1 | 10 |
GO:0048488 | synaptic vesicle endocytosis | 1.22e-02 | 1.00e+00 | 6.347 | 1 | 1 | 10 |
GO:0035855 | megakaryocyte development | 1.22e-02 | 1.00e+00 | 6.347 | 1 | 1 | 10 |
GO:0009306 | protein secretion | 1.34e-02 | 1.00e+00 | 6.209 | 1 | 2 | 11 |
GO:0031333 | negative regulation of protein complex assembly | 1.34e-02 | 1.00e+00 | 6.209 | 1 | 1 | 11 |
GO:0035255 | ionotropic glutamate receptor binding | 1.34e-02 | 1.00e+00 | 6.209 | 1 | 1 | 11 |
GO:0033137 | negative regulation of peptidyl-serine phosphorylation | 1.34e-02 | 1.00e+00 | 6.209 | 1 | 1 | 11 |
GO:0010880 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum | 1.34e-02 | 1.00e+00 | 6.209 | 1 | 1 | 11 |
GO:0030220 | platelet formation | 1.34e-02 | 1.00e+00 | 6.209 | 1 | 1 | 11 |
GO:0045120 | pronucleus | 1.34e-02 | 1.00e+00 | 6.209 | 1 | 1 | 11 |
GO:0030225 | macrophage differentiation | 1.34e-02 | 1.00e+00 | 6.209 | 1 | 1 | 11 |
GO:0046716 | muscle cell cellular homeostasis | 1.34e-02 | 1.00e+00 | 6.209 | 1 | 1 | 11 |
GO:0030742 | GTP-dependent protein binding | 1.34e-02 | 1.00e+00 | 6.209 | 1 | 1 | 11 |
GO:0090316 | positive regulation of intracellular protein transport | 1.34e-02 | 1.00e+00 | 6.209 | 1 | 1 | 11 |
GO:0035267 | NuA4 histone acetyltransferase complex | 1.47e-02 | 1.00e+00 | 6.083 | 1 | 2 | 12 |
GO:0042789 | mRNA transcription from RNA polymerase II promoter | 1.47e-02 | 1.00e+00 | 6.083 | 1 | 1 | 12 |
GO:0015935 | small ribosomal subunit | 1.47e-02 | 1.00e+00 | 6.083 | 1 | 4 | 12 |
GO:0051146 | striated muscle cell differentiation | 1.47e-02 | 1.00e+00 | 6.083 | 1 | 2 | 12 |
GO:0007088 | regulation of mitosis | 1.47e-02 | 1.00e+00 | 6.083 | 1 | 1 | 12 |
GO:0010881 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion | 1.47e-02 | 1.00e+00 | 6.083 | 1 | 1 | 12 |
GO:0048205 | COPI coating of Golgi vesicle | 1.47e-02 | 1.00e+00 | 6.083 | 1 | 1 | 12 |
GO:0008306 | associative learning | 1.47e-02 | 1.00e+00 | 6.083 | 1 | 1 | 12 |
GO:0045445 | myoblast differentiation | 1.59e-02 | 1.00e+00 | 5.968 | 1 | 1 | 13 |
GO:0048821 | erythrocyte development | 1.59e-02 | 1.00e+00 | 5.968 | 1 | 2 | 13 |
GO:0031527 | filopodium membrane | 1.59e-02 | 1.00e+00 | 5.968 | 1 | 1 | 13 |
GO:0051491 | positive regulation of filopodium assembly | 1.59e-02 | 1.00e+00 | 5.968 | 1 | 1 | 13 |
GO:0034185 | apolipoprotein binding | 1.59e-02 | 1.00e+00 | 5.968 | 1 | 1 | 13 |
GO:0016514 | SWI/SNF complex | 1.59e-02 | 1.00e+00 | 5.968 | 1 | 1 | 13 |
GO:0045214 | sarcomere organization | 1.59e-02 | 1.00e+00 | 5.968 | 1 | 1 | 13 |
GO:0060347 | heart trabecula formation | 1.59e-02 | 1.00e+00 | 5.968 | 1 | 1 | 13 |
GO:0046847 | filopodium assembly | 1.71e-02 | 1.00e+00 | 5.861 | 1 | 1 | 14 |
GO:0005790 | smooth endoplasmic reticulum | 1.71e-02 | 1.00e+00 | 5.861 | 1 | 1 | 14 |
GO:0042176 | regulation of protein catabolic process | 1.71e-02 | 1.00e+00 | 5.861 | 1 | 3 | 14 |
GO:0043623 | cellular protein complex assembly | 1.71e-02 | 1.00e+00 | 5.861 | 1 | 1 | 14 |
GO:0002042 | cell migration involved in sprouting angiogenesis | 1.71e-02 | 1.00e+00 | 5.861 | 1 | 1 | 14 |
GO:0045859 | regulation of protein kinase activity | 1.71e-02 | 1.00e+00 | 5.861 | 1 | 1 | 14 |
GO:0043025 | neuronal cell body | 1.79e-02 | 1.00e+00 | 3.251 | 2 | 3 | 171 |
GO:0032839 | dendrite cytoplasm | 1.83e-02 | 1.00e+00 | 5.762 | 1 | 1 | 15 |
GO:2000134 | negative regulation of G1/S transition of mitotic cell cycle | 1.83e-02 | 1.00e+00 | 5.762 | 1 | 1 | 15 |
GO:0045879 | negative regulation of smoothened signaling pathway | 1.83e-02 | 1.00e+00 | 5.762 | 1 | 1 | 15 |
GO:0043034 | costamere | 1.83e-02 | 1.00e+00 | 5.762 | 1 | 1 | 15 |
GO:0030863 | cortical cytoskeleton | 1.83e-02 | 1.00e+00 | 5.762 | 1 | 1 | 15 |
GO:0051017 | actin filament bundle assembly | 1.83e-02 | 1.00e+00 | 5.762 | 1 | 1 | 15 |
GO:1900026 | positive regulation of substrate adhesion-dependent cell spreading | 1.95e-02 | 1.00e+00 | 5.668 | 1 | 1 | 16 |
GO:0032467 | positive regulation of cytokinesis | 1.95e-02 | 1.00e+00 | 5.668 | 1 | 1 | 16 |
GO:0017022 | myosin binding | 1.95e-02 | 1.00e+00 | 5.668 | 1 | 2 | 16 |
GO:0090398 | cellular senescence | 1.95e-02 | 1.00e+00 | 5.668 | 1 | 1 | 16 |
GO:0001829 | trophectodermal cell differentiation | 2.07e-02 | 1.00e+00 | 5.581 | 1 | 1 | 17 |
GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER | 2.07e-02 | 1.00e+00 | 5.581 | 1 | 1 | 17 |
GO:0005737 | cytoplasm | 2.16e-02 | 1.00e+00 | 1.113 | 7 | 39 | 2633 |
GO:0031435 | mitogen-activated protein kinase kinase kinase binding | 2.19e-02 | 1.00e+00 | 5.499 | 1 | 1 | 18 |
GO:0005856 | cytoskeleton | 2.19e-02 | 1.00e+00 | 3.099 | 2 | 3 | 190 |
GO:0031069 | hair follicle morphogenesis | 2.19e-02 | 1.00e+00 | 5.499 | 1 | 1 | 18 |
GO:0005515 | protein binding | 2.26e-02 | 1.00e+00 | 0.829 | 9 | 50 | 4124 |
GO:0030049 | muscle filament sliding | 2.31e-02 | 1.00e+00 | 5.421 | 1 | 1 | 19 |
GO:0001707 | mesoderm formation | 2.31e-02 | 1.00e+00 | 5.421 | 1 | 1 | 19 |
GO:0048565 | digestive tract development | 2.31e-02 | 1.00e+00 | 5.421 | 1 | 1 | 19 |
GO:0071556 | integral component of lumenal side of endoplasmic reticulum membrane | 2.31e-02 | 1.00e+00 | 5.421 | 1 | 1 | 19 |
GO:0001892 | embryonic placenta development | 2.43e-02 | 1.00e+00 | 5.347 | 1 | 1 | 20 |
GO:0032720 | negative regulation of tumor necrosis factor production | 2.43e-02 | 1.00e+00 | 5.347 | 1 | 1 | 20 |
GO:0005761 | mitochondrial ribosome | 2.43e-02 | 1.00e+00 | 5.347 | 1 | 1 | 20 |
GO:0007616 | long-term memory | 2.43e-02 | 1.00e+00 | 5.347 | 1 | 1 | 20 |
GO:0007163 | establishment or maintenance of cell polarity | 2.43e-02 | 1.00e+00 | 5.347 | 1 | 2 | 20 |
GO:0043044 | ATP-dependent chromatin remodeling | 2.43e-02 | 1.00e+00 | 5.347 | 1 | 1 | 20 |
GO:0072686 | mitotic spindle | 2.43e-02 | 1.00e+00 | 5.347 | 1 | 1 | 20 |
GO:0031647 | regulation of protein stability | 2.55e-02 | 1.00e+00 | 5.276 | 1 | 1 | 21 |
GO:0007346 | regulation of mitotic cell cycle | 2.55e-02 | 1.00e+00 | 5.276 | 1 | 1 | 21 |
GO:0045597 | positive regulation of cell differentiation | 2.55e-02 | 1.00e+00 | 5.276 | 1 | 1 | 21 |
GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle | 2.55e-02 | 1.00e+00 | 5.276 | 1 | 1 | 21 |
GO:0002027 | regulation of heart rate | 2.55e-02 | 1.00e+00 | 5.276 | 1 | 1 | 21 |
GO:0019894 | kinesin binding | 2.55e-02 | 1.00e+00 | 5.276 | 1 | 1 | 21 |
GO:0051149 | positive regulation of muscle cell differentiation | 2.67e-02 | 1.00e+00 | 5.209 | 1 | 2 | 22 |
GO:0051084 | 'de novo' posttranslational protein folding | 2.67e-02 | 1.00e+00 | 5.209 | 1 | 1 | 22 |
GO:0048589 | developmental growth | 2.67e-02 | 1.00e+00 | 5.209 | 1 | 1 | 22 |
GO:0008307 | structural constituent of muscle | 2.67e-02 | 1.00e+00 | 5.209 | 1 | 1 | 22 |
GO:0001895 | retina homeostasis | 2.67e-02 | 1.00e+00 | 5.209 | 1 | 1 | 22 |
GO:0043552 | positive regulation of phosphatidylinositol 3-kinase activity | 2.67e-02 | 1.00e+00 | 5.209 | 1 | 1 | 22 |
GO:0040018 | positive regulation of multicellular organism growth | 2.67e-02 | 1.00e+00 | 5.209 | 1 | 1 | 22 |
GO:0061077 | chaperone-mediated protein folding | 2.67e-02 | 1.00e+00 | 5.209 | 1 | 1 | 22 |
GO:0002040 | sprouting angiogenesis | 2.67e-02 | 1.00e+00 | 5.209 | 1 | 1 | 22 |
GO:0034605 | cellular response to heat | 2.67e-02 | 1.00e+00 | 5.209 | 1 | 1 | 22 |
GO:0031424 | keratinization | 2.79e-02 | 1.00e+00 | 5.145 | 1 | 1 | 23 |
GO:0005791 | rough endoplasmic reticulum | 2.79e-02 | 1.00e+00 | 5.145 | 1 | 1 | 23 |
GO:0009725 | response to hormone | 2.91e-02 | 1.00e+00 | 5.083 | 1 | 1 | 24 |
GO:0007030 | Golgi organization | 3.03e-02 | 1.00e+00 | 5.025 | 1 | 2 | 25 |
GO:0051219 | phosphoprotein binding | 3.03e-02 | 1.00e+00 | 5.025 | 1 | 3 | 25 |
GO:0007093 | mitotic cell cycle checkpoint | 3.03e-02 | 1.00e+00 | 5.025 | 1 | 2 | 25 |
GO:0003730 | mRNA 3'-UTR binding | 3.03e-02 | 1.00e+00 | 5.025 | 1 | 1 | 25 |
GO:0031492 | nucleosomal DNA binding | 3.03e-02 | 1.00e+00 | 5.025 | 1 | 1 | 25 |
GO:0003700 | sequence-specific DNA binding transcription factor activity | 3.09e-02 | 1.00e+00 | 2.069 | 3 | 9 | 582 |
GO:0060048 | cardiac muscle contraction | 3.15e-02 | 1.00e+00 | 4.968 | 1 | 1 | 26 |
GO:0019901 | protein kinase binding | 3.17e-02 | 1.00e+00 | 2.810 | 2 | 8 | 232 |
GO:0048666 | neuron development | 3.27e-02 | 1.00e+00 | 4.914 | 1 | 1 | 27 |
GO:0007411 | axon guidance | 3.30e-02 | 1.00e+00 | 2.780 | 2 | 2 | 237 |
GO:0042692 | muscle cell differentiation | 3.39e-02 | 1.00e+00 | 4.861 | 1 | 2 | 28 |
GO:0042059 | negative regulation of epidermal growth factor receptor signaling pathway | 3.39e-02 | 1.00e+00 | 4.861 | 1 | 2 | 28 |
GO:0030155 | regulation of cell adhesion | 3.39e-02 | 1.00e+00 | 4.861 | 1 | 1 | 28 |
GO:0001569 | patterning of blood vessels | 3.51e-02 | 1.00e+00 | 4.810 | 1 | 1 | 29 |
GO:0070527 | platelet aggregation | 3.51e-02 | 1.00e+00 | 4.810 | 1 | 1 | 29 |
GO:0070830 | tight junction assembly | 3.51e-02 | 1.00e+00 | 4.810 | 1 | 1 | 29 |
GO:0051402 | neuron apoptotic process | 3.63e-02 | 1.00e+00 | 4.762 | 1 | 1 | 30 |
GO:0001228 | RNA polymerase II transcription regulatory region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription | 3.63e-02 | 1.00e+00 | 4.762 | 1 | 1 | 30 |
GO:0071333 | cellular response to glucose stimulus | 3.63e-02 | 1.00e+00 | 4.762 | 1 | 2 | 30 |
GO:0050681 | androgen receptor binding | 3.63e-02 | 1.00e+00 | 4.762 | 1 | 2 | 30 |
GO:0021766 | hippocampus development | 3.75e-02 | 1.00e+00 | 4.714 | 1 | 3 | 31 |
GO:0001102 | RNA polymerase II activating transcription factor binding | 3.75e-02 | 1.00e+00 | 4.714 | 1 | 1 | 31 |
GO:0016328 | lateral plasma membrane | 3.75e-02 | 1.00e+00 | 4.714 | 1 | 2 | 31 |
GO:0031490 | chromatin DNA binding | 3.75e-02 | 1.00e+00 | 4.714 | 1 | 1 | 31 |
GO:0019900 | kinase binding | 3.86e-02 | 1.00e+00 | 4.668 | 1 | 2 | 32 |
GO:0045740 | positive regulation of DNA replication | 3.86e-02 | 1.00e+00 | 4.668 | 1 | 1 | 32 |
GO:0035914 | skeletal muscle cell differentiation | 3.98e-02 | 1.00e+00 | 4.624 | 1 | 1 | 33 |
GO:0045944 | positive regulation of transcription from RNA polymerase II promoter | 4.01e-02 | 1.00e+00 | 1.922 | 3 | 8 | 644 |
GO:0001947 | heart looping | 4.10e-02 | 1.00e+00 | 4.581 | 1 | 1 | 34 |
GO:0046330 | positive regulation of JNK cascade | 4.10e-02 | 1.00e+00 | 4.581 | 1 | 1 | 34 |
GO:0030521 | androgen receptor signaling pathway | 4.22e-02 | 1.00e+00 | 4.539 | 1 | 3 | 35 |
GO:0006952 | defense response | 4.46e-02 | 1.00e+00 | 4.459 | 1 | 1 | 37 |
GO:0001948 | glycoprotein binding | 4.46e-02 | 1.00e+00 | 4.459 | 1 | 1 | 37 |
GO:0005925 | focal adhesion | 4.53e-02 | 1.00e+00 | 2.529 | 2 | 12 | 282 |
GO:0010976 | positive regulation of neuron projection development | 4.69e-02 | 1.00e+00 | 4.383 | 1 | 2 | 39 |
GO:0050680 | negative regulation of epithelial cell proliferation | 4.69e-02 | 1.00e+00 | 4.383 | 1 | 1 | 39 |
GO:0005840 | ribosome | 4.81e-02 | 1.00e+00 | 4.347 | 1 | 3 | 40 |
GO:0034097 | response to cytokine | 4.81e-02 | 1.00e+00 | 4.347 | 1 | 1 | 40 |
GO:0042383 | sarcolemma | 4.93e-02 | 1.00e+00 | 4.311 | 1 | 1 | 41 |
GO:0043525 | positive regulation of neuron apoptotic process | 4.93e-02 | 1.00e+00 | 4.311 | 1 | 2 | 41 |
GO:0001047 | core promoter binding | 5.04e-02 | 1.00e+00 | 4.276 | 1 | 1 | 42 |
GO:0045216 | cell-cell junction organization | 5.28e-02 | 1.00e+00 | 4.209 | 1 | 2 | 44 |
GO:0030141 | secretory granule | 5.28e-02 | 1.00e+00 | 4.209 | 1 | 2 | 44 |
GO:0043433 | negative regulation of sequence-specific DNA binding transcription factor activity | 5.39e-02 | 1.00e+00 | 4.177 | 1 | 1 | 45 |
GO:0033138 | positive regulation of peptidyl-serine phosphorylation | 5.74e-02 | 1.00e+00 | 4.083 | 1 | 1 | 48 |
GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding | 5.86e-02 | 1.00e+00 | 4.054 | 1 | 1 | 49 |
GO:0009636 | response to toxic substance | 5.98e-02 | 1.00e+00 | 4.025 | 1 | 1 | 50 |
GO:0001078 | RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription | 5.98e-02 | 1.00e+00 | 4.025 | 1 | 1 | 50 |
GO:0006469 | negative regulation of protein kinase activity | 5.98e-02 | 1.00e+00 | 4.025 | 1 | 1 | 50 |
GO:0060070 | canonical Wnt signaling pathway | 6.09e-02 | 1.00e+00 | 3.996 | 1 | 2 | 51 |
GO:0031295 | T cell costimulation | 6.09e-02 | 1.00e+00 | 3.996 | 1 | 1 | 51 |
GO:0043197 | dendritic spine | 6.09e-02 | 1.00e+00 | 3.996 | 1 | 2 | 51 |
GO:0007596 | blood coagulation | 6.30e-02 | 1.00e+00 | 2.263 | 2 | 4 | 339 |
GO:0045666 | positive regulation of neuron differentiation | 6.33e-02 | 1.00e+00 | 3.941 | 1 | 1 | 53 |
GO:0034329 | cell junction assembly | 6.33e-02 | 1.00e+00 | 3.941 | 1 | 2 | 53 |
GO:0045177 | apical part of cell | 6.44e-02 | 1.00e+00 | 3.914 | 1 | 1 | 54 |
GO:0035264 | multicellular organism growth | 6.44e-02 | 1.00e+00 | 3.914 | 1 | 1 | 54 |
GO:0071260 | cellular response to mechanical stimulus | 6.56e-02 | 1.00e+00 | 3.887 | 1 | 1 | 55 |
GO:0006338 | chromatin remodeling | 6.56e-02 | 1.00e+00 | 3.887 | 1 | 2 | 55 |
GO:0007517 | muscle organ development | 6.67e-02 | 1.00e+00 | 3.861 | 1 | 1 | 56 |
GO:0005509 | calcium ion binding | 6.70e-02 | 1.00e+00 | 2.213 | 2 | 3 | 351 |
GO:0044267 | cellular protein metabolic process | 6.74e-02 | 1.00e+00 | 2.209 | 2 | 13 | 352 |
GO:0042802 | identical protein binding | 6.80e-02 | 1.00e+00 | 2.201 | 2 | 2 | 354 |
GO:0044822 | poly(A) RNA binding | 6.88e-02 | 1.00e+00 | 1.611 | 3 | 25 | 799 |
GO:0003705 | RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity | 6.90e-02 | 1.00e+00 | 3.810 | 1 | 1 | 58 |
GO:0000785 | chromatin | 7.02e-02 | 1.00e+00 | 3.786 | 1 | 2 | 59 |
GO:0007265 | Ras protein signal transduction | 7.02e-02 | 1.00e+00 | 3.786 | 1 | 2 | 59 |
GO:0030336 | negative regulation of cell migration | 7.13e-02 | 1.00e+00 | 3.762 | 1 | 1 | 60 |
GO:0005179 | hormone activity | 7.13e-02 | 1.00e+00 | 3.762 | 1 | 1 | 60 |
GO:0007160 | cell-matrix adhesion | 7.25e-02 | 1.00e+00 | 3.738 | 1 | 1 | 61 |
GO:0018279 | protein N-linked glycosylation via asparagine | 7.25e-02 | 1.00e+00 | 3.738 | 1 | 1 | 61 |
GO:0010629 | negative regulation of gene expression | 7.36e-02 | 1.00e+00 | 3.714 | 1 | 2 | 62 |
GO:0019886 | antigen processing and presentation of exogenous peptide antigen via MHC class II | 7.59e-02 | 1.00e+00 | 3.668 | 1 | 3 | 64 |
GO:0042470 | melanosome | 7.59e-02 | 1.00e+00 | 3.668 | 1 | 2 | 64 |
GO:0004888 | transmembrane signaling receptor activity | 7.93e-02 | 1.00e+00 | 3.602 | 1 | 1 | 67 |
GO:0001764 | neuron migration | 7.93e-02 | 1.00e+00 | 3.602 | 1 | 2 | 67 |
GO:0051091 | positive regulation of sequence-specific DNA binding transcription factor activity | 7.93e-02 | 1.00e+00 | 3.602 | 1 | 1 | 67 |
GO:0006325 | chromatin organization | 8.28e-02 | 1.00e+00 | 3.539 | 1 | 2 | 70 |
GO:0051082 | unfolded protein binding | 8.28e-02 | 1.00e+00 | 3.539 | 1 | 1 | 70 |
GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I | 8.28e-02 | 1.00e+00 | 3.539 | 1 | 4 | 70 |
GO:0006928 | cellular component movement | 8.28e-02 | 1.00e+00 | 3.539 | 1 | 3 | 70 |
GO:0030496 | midbody | 8.62e-02 | 1.00e+00 | 3.479 | 1 | 3 | 73 |
GO:0014069 | postsynaptic density | 8.62e-02 | 1.00e+00 | 3.479 | 1 | 2 | 73 |
GO:0051056 | regulation of small GTPase mediated signal transduction | 8.95e-02 | 1.00e+00 | 3.421 | 1 | 1 | 76 |
GO:0005815 | microtubule organizing center | 9.07e-02 | 1.00e+00 | 3.402 | 1 | 2 | 77 |
GO:0016605 | PML body | 9.29e-02 | 1.00e+00 | 3.365 | 1 | 1 | 79 |
GO:0030246 | carbohydrate binding | 9.40e-02 | 1.00e+00 | 3.347 | 1 | 1 | 80 |
GO:0005819 | spindle | 9.40e-02 | 1.00e+00 | 3.347 | 1 | 2 | 80 |
GO:0072562 | blood microparticle | 9.52e-02 | 1.00e+00 | 3.329 | 1 | 1 | 81 |
GO:0030529 | ribonucleoprotein complex | 9.63e-02 | 1.00e+00 | 3.311 | 1 | 3 | 82 |
GO:0045087 | innate immune response | 1.04e-01 | 1.00e+00 | 1.848 | 2 | 6 | 452 |
GO:0006886 | intracellular protein transport | 1.04e-01 | 1.00e+00 | 3.193 | 1 | 1 | 89 |
GO:0030036 | actin cytoskeleton organization | 1.05e-01 | 1.00e+00 | 3.177 | 1 | 2 | 90 |
GO:0007050 | cell cycle arrest | 1.07e-01 | 1.00e+00 | 3.145 | 1 | 2 | 92 |
GO:0032496 | response to lipopolysaccharide | 1.09e-01 | 1.00e+00 | 3.129 | 1 | 1 | 93 |
GO:0046983 | protein dimerization activity | 1.10e-01 | 1.00e+00 | 3.114 | 1 | 2 | 94 |
GO:0007568 | aging | 1.13e-01 | 1.00e+00 | 3.069 | 1 | 1 | 97 |
GO:0005198 | structural molecule activity | 1.17e-01 | 1.00e+00 | 3.010 | 1 | 1 | 101 |
GO:0005911 | cell-cell junction | 1.21e-01 | 1.00e+00 | 2.968 | 1 | 2 | 104 |
GO:0005788 | endoplasmic reticulum lumen | 1.21e-01 | 1.00e+00 | 2.968 | 1 | 2 | 104 |
GO:0007507 | heart development | 1.23e-01 | 1.00e+00 | 2.941 | 1 | 1 | 106 |
GO:0010628 | positive regulation of gene expression | 1.23e-01 | 1.00e+00 | 2.941 | 1 | 2 | 106 |
GO:0003735 | structural constituent of ribosome | 1.26e-01 | 1.00e+00 | 2.900 | 1 | 8 | 109 |
GO:0045211 | postsynaptic membrane | 1.27e-01 | 1.00e+00 | 2.887 | 1 | 2 | 110 |
GO:0042981 | regulation of apoptotic process | 1.29e-01 | 1.00e+00 | 2.861 | 1 | 4 | 112 |
GO:0043005 | neuron projection | 1.30e-01 | 1.00e+00 | 2.848 | 1 | 2 | 113 |
GO:0001666 | response to hypoxia | 1.34e-01 | 1.00e+00 | 2.810 | 1 | 1 | 116 |
GO:0043687 | post-translational protein modification | 1.34e-01 | 1.00e+00 | 2.810 | 1 | 1 | 116 |
GO:0003924 | GTPase activity | 1.37e-01 | 1.00e+00 | 2.774 | 1 | 3 | 119 |
GO:0006351 | transcription, DNA-templated | 1.38e-01 | 1.00e+00 | 1.182 | 3 | 15 | 1076 |
GO:0045121 | membrane raft | 1.42e-01 | 1.00e+00 | 2.714 | 1 | 1 | 124 |
GO:0000082 | G1/S transition of mitotic cell cycle | 1.43e-01 | 1.00e+00 | 2.703 | 1 | 6 | 125 |
GO:0006184 | GTP catabolic process | 1.49e-01 | 1.00e+00 | 2.646 | 1 | 3 | 130 |
GO:0001077 | RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription | 1.51e-01 | 1.00e+00 | 2.624 | 1 | 2 | 132 |
GO:0015629 | actin cytoskeleton | 1.55e-01 | 1.00e+00 | 2.581 | 1 | 3 | 136 |
GO:0031625 | ubiquitin protein ligase binding | 1.57e-01 | 1.00e+00 | 2.560 | 1 | 2 | 138 |
GO:0030168 | platelet activation | 1.60e-01 | 1.00e+00 | 2.529 | 1 | 3 | 141 |
GO:0005886 | plasma membrane | 1.61e-01 | 1.00e+00 | 0.868 | 4 | 13 | 1784 |
GO:0007173 | epidermal growth factor receptor signaling pathway | 1.61e-01 | 1.00e+00 | 2.519 | 1 | 3 | 142 |
GO:0005829 | cytosol | 1.62e-01 | 1.00e+00 | 0.865 | 4 | 33 | 1787 |
GO:0007399 | nervous system development | 1.72e-01 | 1.00e+00 | 2.421 | 1 | 1 | 152 |
GO:0005634 | nucleus | 1.76e-01 | 1.00e+00 | 0.589 | 6 | 40 | 3246 |
GO:0005615 | extracellular space | 1.88e-01 | 1.00e+00 | 1.322 | 2 | 2 | 651 |
GO:0007283 | spermatogenesis | 1.88e-01 | 1.00e+00 | 2.276 | 1 | 2 | 168 |
GO:0007264 | small GTPase mediated signal transduction | 1.94e-01 | 1.00e+00 | 2.225 | 1 | 4 | 174 |
GO:0006412 | translation | 1.98e-01 | 1.00e+00 | 2.193 | 1 | 13 | 178 |
GO:0003779 | actin binding | 1.99e-01 | 1.00e+00 | 2.185 | 1 | 1 | 179 |
GO:0003713 | transcription coactivator activity | 2.04e-01 | 1.00e+00 | 2.145 | 1 | 3 | 184 |
GO:0005525 | GTP binding | 2.17e-01 | 1.00e+00 | 2.046 | 1 | 3 | 197 |
GO:0043065 | positive regulation of apoptotic process | 2.22e-01 | 1.00e+00 | 2.010 | 1 | 3 | 202 |
GO:0030154 | cell differentiation | 2.24e-01 | 1.00e+00 | 1.996 | 1 | 2 | 204 |
GO:0030054 | cell junction | 2.37e-01 | 1.00e+00 | 1.900 | 1 | 3 | 218 |
GO:0030198 | extracellular matrix organization | 2.40e-01 | 1.00e+00 | 1.881 | 1 | 1 | 221 |
GO:0003682 | chromatin binding | 2.69e-01 | 1.00e+00 | 1.691 | 1 | 3 | 252 |
GO:0000139 | Golgi membrane | 2.83e-01 | 1.00e+00 | 1.608 | 1 | 4 | 267 |
GO:0005654 | nucleoplasm | 2.93e-01 | 1.00e+00 | 0.894 | 2 | 16 | 876 |
GO:0009986 | cell surface | 3.05e-01 | 1.00e+00 | 1.484 | 1 | 1 | 291 |
GO:0006468 | protein phosphorylation | 3.13e-01 | 1.00e+00 | 1.435 | 1 | 3 | 301 |
GO:0000278 | mitotic cell cycle | 3.25e-01 | 1.00e+00 | 1.374 | 1 | 9 | 314 |
GO:0003677 | DNA binding | 3.27e-01 | 1.00e+00 | 0.781 | 2 | 12 | 947 |
GO:0045892 | negative regulation of transcription, DNA-templated | 3.27e-01 | 1.00e+00 | 1.360 | 1 | 1 | 317 |
GO:0006366 | transcription from RNA polymerase II promoter | 3.47e-01 | 1.00e+00 | 1.255 | 1 | 2 | 341 |
GO:0048471 | perinuclear region of cytoplasm | 3.50e-01 | 1.00e+00 | 1.242 | 1 | 7 | 344 |
GO:0045893 | positive regulation of transcription, DNA-templated | 3.77e-01 | 1.00e+00 | 1.110 | 1 | 6 | 377 |
GO:0005783 | endoplasmic reticulum | 3.80e-01 | 1.00e+00 | 1.095 | 1 | 3 | 381 |
GO:0005789 | endoplasmic reticulum membrane | 3.85e-01 | 1.00e+00 | 1.072 | 1 | 3 | 387 |
GO:0042803 | protein homodimerization activity | 4.16e-01 | 1.00e+00 | 0.927 | 1 | 4 | 428 |
GO:0016032 | viral process | 4.16e-01 | 1.00e+00 | 0.927 | 1 | 13 | 428 |
GO:0000122 | negative regulation of transcription from RNA polymerase II promoter | 4.37e-01 | 1.00e+00 | 0.836 | 1 | 6 | 456 |
GO:0007165 | signal transduction | 5.44e-01 | 1.00e+00 | 0.397 | 1 | 5 | 618 |
GO:0006355 | regulation of transcription, DNA-templated | 5.99e-01 | 1.00e+00 | 0.187 | 1 | 9 | 715 |
GO:0008270 | zinc ion binding | 6.05e-01 | 1.00e+00 | 0.163 | 1 | 5 | 727 |
GO:0005524 | ATP binding | 6.83e-01 | 1.00e+00 | -0.132 | 1 | 10 | 892 |
GO:0005730 | nucleolus | 7.98e-01 | 1.00e+00 | -0.581 | 1 | 21 | 1217 |
GO:0016021 | integral component of membrane | 8.70e-01 | 1.00e+00 | -0.907 | 1 | 3 | 1526 |